Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04800965 · ClinicalTrials.gov registry record · NA
Text-based Interventions to Promote COVID-19 Vaccinations
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 200,000
- Enrollment target
NCT04800965: Completed NA study, sponsored by University of California, Los Angeles.
NCT04800965 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 200,000 participants, above the 1,400-participant average among 58,714 other NA trials with a reported enrollment target (14186% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04800965, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 200,000 participants
- Enrollment target
Study Summary
This study investigates whether and which type of text-based interventions affect the take-up of the COVID-19 vaccine.
Primary Outcome
Whether patients schedule their vaccination appointment at UCLA Health within 6 days of receiving the text message (including the day of text message). Specifically, if t=the date of the text message (for the holdout arm, this refers to the date they would have received the text message had they not been assigned to the holdout arm), we will track vaccination appointments made by the end of t+5. While most people just make one appointment, a small percentage update their appointment time. We wil
Interventions
- BEHAVIORAL Patient MyChart Scheduling Link
- BEHAVIORAL Patient Educational Video
- BEHAVIORAL Enhanced Follow through Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2021-01-31 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
What the finished NCT04800965 record still lists
NCT04800965 is an interventional study that assigns participants to a tested intervention. Its 200,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,400-participant average among 58,714 other NA trials with a reported enrollment target (14186% higher).
The record links to 0 conditions, and to 3 interventions - of which Patient MyChart Scheduling Link is the first listed.
NCT04800965 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04800965 about?
NCT04800965 is a clinical study titled "Text-based Interventions to Promote COVID-19 Vaccinations". This study investigates whether and which type of text-based interventions affect the take-up of the COVID-19 vaccine.
What is the current status of trial NCT04800965?
This trial is currently completed. It is a NA study. The enrollment target is 200,000 participants. The study started on 2021-01-31. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04800965?
The interventions under investigation include: Patient MyChart Scheduling Link (BEHAVIORAL), Patient Educational Video (BEHAVIORAL), Enhanced Follow through Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT04800965?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04800965's enrollment target sits among peer trials
200,000 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI